Company Filing History:
Years Active: 2024
Title: Shikhar Mehrotra: Innovator in Anti-Tumor Immunotherapy
Introduction
Shikhar Mehrotra is a notable inventor based in Mount Pleasant, SC (US). He has made significant contributions to the field of immunotherapy, particularly in cancer treatment. His innovative work focuses on the metabolic processes that can enhance anti-tumor responses.
Latest Patents
Shikhar Mehrotra holds a patent titled "CD38-NAD+ regulated metabolic axis in anti-tumor immunotherapy." This patent outlines methods for producing hybrid Th1/Th17 cells. It also provides methods for treating cancer by targeting the CD38-mediated metabolic axis. This innovative approach has the potential to improve therapeutic outcomes for cancer patients.
Career Highlights
Shikhar Mehrotra is associated with the MUSC Foundation for Research Development. His work at this institution emphasizes the importance of research and development in advancing medical science. His dedication to innovation in immunotherapy showcases his commitment to improving cancer treatment.
Collaborations
Shikhar collaborates with Shilpak Chatterjee, contributing to the advancement of research in their field. Their partnership highlights the importance of teamwork in scientific discovery.
Conclusion
Shikhar Mehrotra is a pioneering inventor whose work in anti-tumor immunotherapy is making a significant impact in the fight against cancer. His innovative approaches and dedication to research are paving the way for future advancements in medical treatments.